Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of testosterone [Androgel] replacement on atherosclerosis progression in older men with low testosterone levels.

Trial Profile

Effects of testosterone [Androgel] replacement on atherosclerosis progression in older men with low testosterone levels.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms TEAAM
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 Apr 2017 Results from 2 randomized trials (TAP and TEAAM) presented at The 99th Annual Meeting of the Endocrine Society
    • 19 Dec 2016 Results of two studies (TAP and TEAAM) published in the Journal of Clinical Endocrinology and Metabolism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top